Luk Vandenberghe
Fondatore presso Affinia Therapeutics, Inc.
Posizioni attive di Luk Vandenberghe
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | 01/02/2019 | - |
Fondatore | 01/01/2019 | - | |
Grousbeck Gene Therapy Center | Direttore/Membro del Consiglio | 01/01/2014 | - |
Harvard Medical School | Corporate Officer/Principal | 01/04/2013 | - |
Odylia Therapeutics | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Addgene, Inc.
Addgene, Inc. Miscellaneous Commercial ServicesCommercial Services Addgene, Inc. is a non-profit organization based in Watertown, MA that operates a biorepository for researchers. The non-profit company is based in Cambridge, MA. The company's collection contains over 100,000 plasmids contributed by more than 5,000 research labs worldwide. Addgene also provides over 700 ready-to-use AAV and lentivirus preparations of commonly requested plasmids as a service to scientists. The company has distributed over 1.6 million plasmids to 108 countries. Addgene is creating a lasting resource for research and discovery scientists around the world by authenticating, storing, archiving, and distributing plasmids, antibodies, viral vectors, and their associated data. The company offers educational resources such as ebooks, science guides, videos, and protocols. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Luk Vandenberghe
Precedenti posizioni note di Luk Vandenberghe
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENSIGHT BIOLOGICS S.A. | Fondatore | 01/11/2011 | - |
AKOUOS | Fondatore | 01/01/2016 | - |
Albamunity, Inc.
Albamunity, Inc. Medical DistributorsDistribution Services Albamunity, Inc. engages in the pharmaceutical business. The company is headquartered in Boston, MA. | Fondatore | - | - |
Formazione di Luk Vandenberghe
Katholieke Universiteit Leuven | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Belgio | 2 |
Francia | 2 |
Posizioni
Founder | 5 |
Director/Board Member | 4 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
Aziende private | 6 |
---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Grousbeck Gene Therapy Center | |
Odylia Therapeutics | |
Albamunity, Inc.
Albamunity, Inc. Medical DistributorsDistribution Services Albamunity, Inc. engages in the pharmaceutical business. The company is headquartered in Boston, MA. | Distribution Services |
Addgene, Inc.
Addgene, Inc. Miscellaneous Commercial ServicesCommercial Services Addgene, Inc. is a non-profit organization based in Watertown, MA that operates a biorepository for researchers. The non-profit company is based in Cambridge, MA. The company's collection contains over 100,000 plasmids contributed by more than 5,000 research labs worldwide. Addgene also provides over 700 ready-to-use AAV and lentivirus preparations of commonly requested plasmids as a service to scientists. The company has distributed over 1.6 million plasmids to 108 countries. Addgene is creating a lasting resource for research and discovery scientists around the world by authenticating, storing, archiving, and distributing plasmids, antibodies, viral vectors, and their associated data. The company offers educational resources such as ebooks, science guides, videos, and protocols. | Commercial Services |
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Luk Vandenberghe
- Esperienza